527 results
TAVI - New indications, techniques and devices - Part 1
19 Nov 2023 – From PCR London Valves 2023
Controversies in atrioventricular valves - The Heart Team ring, Vol II
19 Nov 2023 – From PCR London Valves 2023
This session offers an opportunity to engage in a real case discussion led by an advanced Heart Team. Participate in discussions on controversial decision-making scenarios and stay informed about the latest clinical evidence related to MitraClip, Tendyne, and TriClip therapies.
Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...
19 Nov 2023 – From PCR London Valves 2023
Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND study two-year outcomes: transfemoral TTVR
- Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
- One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
- TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
- Real-world...
TAVI in bicuspid anatomy - Part 1
19 Nov 2023 – From PCR London Valves 2023
Delve into the complexities of TAVI within bicuspid anatomy through this selection of cases: encounter a challenging scenario with a bicuspid aortic valve, where the ejection fraction is -14%, coupled with left ventricle thrombus and an aortic valve calcium score reaching 11,000, learn more about the...
The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...
19 Nov 2023 – From PCR London Valves 2023
Discover the top late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
- Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
- Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
- Artificial intelligence derived risk...
Tricuspid TEER - Part 1
19 Nov 2023 – From PCR London Valves 2023
Gain insights into Tricuspid Transcatheter Edge-to-Edge Repair (TEER) with this session: explore the congestion patterns observed in severe tricuspid regurgitation and gain a deeper understanding of transcatheter treatment modalities, delve into the baseline characteristics of the Tri.Fr randomized trial on treating tricuspid regurgitation, witness the application...
The catheter-based treatment revolution is just getting started
19 Nov 2023 – From PCR London Valves 2023
Consult this session to stay updated on the latest advancements in transcatheter aortic valve implantations and interventions for tricuspid regurgitation. Gain insights into how recent evidence and innovations are reshaping the treatment landscape for valvular heart disease.
TAVI - computer simulation and pre-procedural modelling
19 Nov 2023 – From PCR London Valves 2023
TAVI - computer simulation and pre-procedural modelling
19 Nov 2023 – From PCR London Valves 2023
Key questions in tricuspid valve intervention - How does the role of the right heart and pulmonary vasculature influence patient selection?
19 Nov 2023 – From PCR London Valves 2023
Explore insights from an 86-year-old female patient's case with TAVR since end-2022 who presented with permanent AF, moderate MR and TR regurgitation, and learn more about right heart catheterisation for patient selection, CT and CMR in tricuspid interventions, criteria for atrial secondary TR, and more!
